Macquarie Emerging Markets Fund A
DEMAX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 100 Independence Philadelphia PA United States of America 19106-2354
- IPO Date
- Jun 10, 1996
- CIK
- 0000875610
- Website
- macquarie.com
- Similar Companies
- Business
- Delaware Emerging Markets Fund A Class (DEMAX) is an open-end mutual fund that seeks long-term capital appreciation by investing primarily in equity securities of companies located in emerging market countries, including those in the Asia-Pacific region, Eastern Europe, the Middle East, Central America, South America, and Africa. Under normal circumstances, the fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in emerging market issuers, with a focus on large-blend style diversified emerging markets equities; top holdings include Taiwan Semiconductor Manufacturing Co Ltd (16.11%), SK Hynix Inc (8.92%), SK Square (7.95%), Reliance Industries Ltd (6.74%), and Samsung Electronics Co Ltd (5.71%), spanning sectors such as technology, energy, consumer cyclical, communication services, and industrials. The fund offers Class A shares with a front-load structure, minimum initial investment of $1,000, adjusted expense ratio of 1.420%, TTM yield of 2.43%, and low portfolio turnover of 2%, managed within the Diversified Emerging Mkts category. It targets institutional and retail investors seeking exposure to emerging markets growth, with total assets under management of approximately $5.8 billion as of late 2024. Incepted on November 25, 1996, the fund is managed by Delaware Management Company, a series of Macquarie Investment Management Business Trust, part of Macquarie Asset Management, with portfolio management led by Liu-Er Chen, CFA, Senior Vice President and Chief Investment Officer for Emerging Markets and Healthcare; the firm may utilize affiliated sub-advisors such as Macquarie Investment Management Global Limited for specialized market execution. Headquartered in Philadelphia, Pennsylvania, as part of the legacy Delaware Funds platform under Macquarie Group, the fund benefits from the parent's global capabilities while retaining the Delaware branding for U.S. retail mutual fund offerings following the 2017 rebranding of Delaware Investments to Macquarie Investment Management. Recent developments include a significant portfolio management transition effective August 15, 2024, with Benjamin Leung and Samir Vanza appointed as portfolio managers alongside ongoing leadership, reflecting strategic enhancements to the emerging markets debt and equity teams within Macquarie Asset Management. In September 2024, Macquarie Asset Management launched the Macquarie Focused Emerging Markets Equity ETF (EMEQ), applying the same time-tested investment philosophy and team as DEMAX, including Liu-Er Chen's 29-year experience, to broaden access to the strategy with a competitive 0.85% expense ratio. The fund maintained strong performance into 2025, with Q1 and Q3 commentaries highlighting outperformance versus the MSCI Emerging Markets Index (net) amid allocations to high-conviction names in South Korea (24.96%), Taiwan (23.25%), China (16.27%), and India (15.69%).